作者: Karen Chiam , Tanya Kate Day , Tina Bianco-Miotto
DOI: 10.1007/978-94-007-6612-9_8
关键词:
摘要: Epigenetics refers to DNA methylation, histone modifications and microRNAs these epigenetic are extensively investigated as potential biomarkers for cancer. Characterizing genome wide changes involved in prostate cancer development progression will not only identify novel therapeutic targets, since some reversible, but also highlight which can be used biomarkers. Epigenetic relatively stable easy measure peripheral samples like blood urine, further highlighting their importance powerful tools assessing patient diagnosis prognosis. In this review, we outline how have been diagnosis, prognosis monitoring response We review may more sensitive specific than current serum markers the possibility that combining different enhance diagnostic prognostic ability of As epigenome studies continue performed larger cohorts, soon tumorigenesis with resultant identification new targets robust